Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review

Overview

Journal Nutrients

Date 2020 Jun 21

PMID 32560503

Citations 50

Authors

Jana Wells

Arun Swaminathan

Jenna Paseka

Corrine Hanson

Affiliations

Soon will be listed here.

Abstract

Epilepsy in the pediatric and adolescent populations is a devastating condition where individuals are prone to recurrent epileptic seizures or changes in behavior or movement that is the direct result of a primary change in the electrical activity in the brain. Although many children with epilepsy will have seizures controlled with antiseizure medications (ASMs), a large percentage of patients are refractory to drug therapy and may consider initiating a ketogenic diet. The term Ketogenic Diet or Ketogenic Diet Therapy (KDT) refers to any diet therapy in which dietary composition results in a ketogenic state of human metabolism. Currently, there are 4 major Ketogenic diet therapies-the classic ketogenic diet (cKD), the modified Atkins diet (MAD), the medium chain triglyceride ketogenic diet (MCTKD) and the low glycemic index treatment (LGIT). The compositions of the 4 main KDTs differ and limited evidence to distinguish the efficacy among different diets currently exists. Although it is apparent that more randomized controlled trials (RCTs) and long-term studies are needed to evaluate efficacy, side effects and individual response to the diet, it is imperative to study and understand the metabolic profiles of patients with epilepsy in order to isolate which dietary restrictions are necessary to maximize clinical benefit.

Citing Articles

Ketogenic diets and β-hydroxybutyrate in the prevention and treatment of diabetic kidney disease: current progress and future perspectives.

Li J, He W, Wu Q, Qin Y, Luo C, Dai Z BMC Nephrol. 2025; 26(1):127.

PMID: 40055596 PMC: 11887203. DOI: 10.1186/s12882-025-04019-0.

Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy.

Luo C, Dai Z, He W, He Y, Yang P, Huang M Front Nutr. 2025; 12:1508695.

PMID: 39917743 PMC: 11798809. DOI: 10.3389/fnut.2025.1508695.

Ketogenic diet in treating sepsis-related acquired weakness: is it friend or foe?.

Miao Y, Xie L, Chen S, Zhang X, Liu W, Xie P Front Nutr. 2024; 11:1484856.

PMID: 39668897 PMC: 11636000. DOI: 10.3389/fnut.2024.1484856.

Ketogenic diets in clinical psychology: examining the evidence and implications for practice.

Laurent N, Bellamy E, Hristova D, Houston A Front Psychol. 2024; 15:1468894.

PMID: 39391844 PMC: 11464436. DOI: 10.3389/fpsyg.2024.1468894.

Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.

Briglia M, Allia F, Avola R, Signorini C, Cardile V, Romano G Nutrients. 2024; 16(18).

PMID: 39339713 PMC: 11435074. DOI: 10.3390/nu16183114.

References

Laffel L . Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 2000; 15(6):412-26. DOI: 10.1002/(sici)1520-7560(199911/12)15:6<412::aid-dmrr72>3.0.co;2-8. View

Simm P, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart K . The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 2017; 136:62-66. DOI: 10.1016/j.eplepsyres.2017.07.014. View

Thavendiranathan P, Chow C, Cunnane S, Burnham W . The effect of the 'classic' ketogenic diet on animal seizure models. Brain Res. 2002; 959(2):206-13. DOI: 10.1016/s0006-8993(02)03744-7. View

Wheless J . History of the ketogenic diet. Epilepsia. 2008; 49 Suppl 8:3-5. DOI: 10.1111/j.1528-1167.2008.01821.x. View

Lee H, Chi C, Liao J . Use of cooking oils in a 2:1 ratio classical ketogenic diet for intractable pediatric epilepsy: Long-term effectiveness and tolerability. Epilepsy Res. 2018; 147:75-79. DOI: 10.1016/j.eplepsyres.2018.09.002. View

Dressler A, Trimmel-Schwahofer P, Reithofer E, Groppel G, Muhlebner A, Samueli S . The ketogenic diet in infants--Advantages of early use. Epilepsy Res. 2015; 116:53-8. DOI: 10.1016/j.eplepsyres.2015.06.015. View

Wlaz P, Socala K, Nieoczym D, Luszczki J, Zarnowska I, Zarnowski T . Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology. 2012; 62(4):1882-9. DOI: 10.1016/j.neuropharm.2011.12.015. View

Vahmani P, Ponnampalam E, Kraft J, Mapiye C, Bermingham E, Watkins P . Bioactivity and health effects of ruminant meat lipids. Invited Review. Meat Sci. 2020; 165:108114. DOI: 10.1016/j.meatsci.2020.108114. View

Kossoff E, Zupec-Kania B, Amark P, Ballaban-Gil K, Bergqvist A, Blackford R . Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2008; 50(2):304-17. DOI: 10.1111/j.1528-1167.2008.01765.x. View

10.

Chul Kang H, Kim Y, Kim D, Kim H . Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia. 2005; 46(2):272-9. DOI: 10.1111/j.0013-9580.2005.48504.x. View

11.

Martin K, Jackson C, Levy R, Cooper P . Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2016; 2:CD001903. DOI: 10.1002/14651858.CD001903.pub3. View

12.

Bank I, Shemie S, Rosenblatt B, Bernard C, Mackie A . Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol. 2008; 39(6):429-31. DOI: 10.1016/j.pediatrneurol.2008.08.013. View

13.

Cervenka M, Kossoff E . Dietary treatment of intractable epilepsy. Continuum (Minneap Minn). 2013; 19(3 Epilepsy):756-66. PMC: 10563885. DOI: 10.1212/01.CON.0000431396.23852.56. View

14.

Edmond J, Auestad N, Robbins R, Bergstrom J . Ketone body metabolism in the neonate: development and the effect of diet. Fed Proc. 1985; 44(7):2359-64. View

15.

Neal E, Chaffe H, Schwartz R, Lawson M, Edwards N, Fitzsimmons G . A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2008; 50(5):1109-17. DOI: 10.1111/j.1528-1167.2008.01870.x. View

16.

Musto A, Rosencrans R, Walker C, Bhattacharjee S, Raulji C, Belayev L . Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Sci Rep. 2016; 6:30298. PMC: 4957208. DOI: 10.1038/srep30298. View

17.

Chang P, Terbach N, Plant N, Chen P, Walker M, Williams R . Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology. 2012; 69:105-14. PMC: 3625124. DOI: 10.1016/j.neuropharm.2012.11.004. View

18.

Groesbeck D, Bluml R, Kossoff E . Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006; 48(12):978-81. DOI: 10.1017/S0012162206002143. View

19.

Cahill Jr G . Fuel metabolism in starvation. Annu Rev Nutr. 2006; 26:1-22. DOI: 10.1146/annurev.nutr.26.061505.111258. View

20.

Miranda M, Mortensen M, Povlsen J, Nielsen H, Beniczky S . Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet?. Seizure. 2010; 20(2):151-5. DOI: 10.1016/j.seizure.2010.11.010. View